InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Verastem, Inc.

VSTM Clue Score56
United States Fiscal year ends December CIK 0001526119
$8.38 +3.33% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $8.38 +198.22% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−37.0Net income−36.4EPS, diluted−0.99Fiscal year 2017Operating income−67.8Net income−67.8EPS, diluted−1.76Fiscal year 2018Revenue26.7Operating income−94.8Net income−72.4EPS, diluted−1.37Fiscal year 2019Revenue17.5 −34.7%Operating income−132.3Net income−149.2EPS, diluted−2.00Fiscal year 2020Revenue88.5 +407.1%Operating income−49.4Net income−67.7EPS, diluted−0.44Fiscal year 2021Revenue2.1 −97.7%Operating income−61.4Net income−71.2EPS, diluted−4.90Fiscal year 2022Revenue2.6 +26.4%Operating income−72.9Net income−73.8EPS, diluted−4.57Fiscal year 2023Operating income−92.1Net income−87.4EPS, diluted−3.96Fiscal year 2024Revenue10.0Operating income−115.0Net income−130.6EPS, diluted−3.66Fiscal year 2025Revenue30.9 +209.1%Operating income−170.1Net income−209.5EPS, diluted−3.02
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 26.7 17.5 88.5 2.1 2.6 n/a 10.0 30.9
Growth −34.7% +407.1% −97.7% +26.4% +209.1%
Operating income −37.0 −67.8 −94.8 −132.3 −49.4 −61.4 −72.9 −92.1 −115.0 −170.1
Net income −36.4 −67.8 −72.4 −149.2 −67.7 −71.2 −73.8 −87.4 −130.6 −209.5
Growth
EPS, diluted −0.99 −1.76 −1.37 −2.00 −0.44 −4.90 −4.57 −3.96 −3.66 −3.02

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Operating margin−354.8%Net margin−271.1%Free cash flow margin−284.5%Fiscal year 2019Operating margin−758.1%Net margin−854.8%Free cash flow margin−793.6%Fiscal year 2020Operating margin−55.8%Net margin−76.5%Free cash flow margin−37.9%Fiscal year 2021Operating margin−2,991.2%Net margin−3,468.1%Free cash flow margin−2,615.6%Fiscal year 2022Operating margin−2,809.6%Net margin−2,843.3%Fiscal year 2023Fiscal year 2024Operating margin−1,149.6%Net margin−1,306.4%Free cash flow margin−1,048.0%Fiscal year 2025Operating margin−550.3%Net margin−677.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −354.8% −758.1% −55.8% −2,991.2% −2,809.6% n/a −1,149.6% −550.3%
Net margin n/a n/a −271.1% −854.8% −76.5% −3,468.1% −2,843.3% n/a −1,306.4% −677.6%
Free cash flow margin n/a n/a −284.5% −793.6% −37.9% −2,615.6% n/a n/a −1,048.0% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−29.5Capital expenditure−0.0Free cash flow−29.5Fiscal year 2017Operating cash flow−57.3Fiscal year 2018Operating cash flow−74.5Capital expenditure−1.5Free cash flow−76.0Fiscal year 2019Operating cash flow−138.5Capital expenditure−0.0Free cash flow−138.5Fiscal year 2020Operating cash flow−33.5Capital expenditure−0.0Free cash flow−33.5Fiscal year 2021Operating cash flow−53.5Capital expenditure−0.2Free cash flow−53.7Fiscal year 2022Operating cash flow−63.7Fiscal year 2023Operating cash flow−86.5Fiscal year 2024Operating cash flow−104.8Capital expenditure−0.0Free cash flow−104.8Fiscal year 2025Operating cash flow−137.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −29.5 −57.3 −74.5 −138.5 −33.5 −53.5 −63.7 −86.5 −104.8 −137.5
Capital expenditure −0.0 n/a −1.5 −0.0 −0.0 −0.2 n/a n/a −0.0 n/a
Free cash flow −29.5 n/a −76.0 −138.5 −33.5 −53.7 n/a n/a −104.8 n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash32.3Shareholders’ equity72.3Fiscal year 2017Cash82.2Total debt14.8Net cash (debt)67.3Shareholders’ equity57.7Debt to equity0.26Fiscal year 2018Cash129.9Total debt25.2Net cash (debt)104.7Shareholders’ equity124.3Debt to equity0.20Fiscal year 2019Cash43.5Total debt35.1Net cash (debt)8.4Shareholders’ equity7.2Debt to equity4.89Fiscal year 2020Cash67.8Shareholders’ equity115.3Fiscal year 2021Cash21.3Shareholders’ equity87.6Fiscal year 2022Cash74.9Total debt24.5Net cash (debt)50.4Shareholders’ equity47.4Debt to equity0.52Fiscal year 2023Cash77.9Total debt40.1Net cash (debt)37.8Shareholders’ equity57.4Debt to equity0.70Fiscal year 2024Cash88.8Total debt40.7Net cash (debt)48.1Shareholders’ equity−28.9Fiscal year 2025Cash205.0Shareholders’ equity57.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 32.3 82.2 129.9 43.5 67.8 21.3 74.9 77.9 88.8 205.0
Total debt n/a 14.8 25.2 35.1 n/a n/a 24.5 40.1 40.7 n/a
Net cash (debt) n/a 67.3 104.7 8.4 n/a n/a 50.4 37.8 48.1 n/a
Shareholders’ equity 72.3 57.7 124.3 7.2 115.3 87.6 47.4 57.4 −28.9 57.2
Debt to equity n/a 0.26 0.20 4.89 n/a n/a 0.52 0.70 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018† 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
n/a n/a 26.7 17.5 88.5 2.1 2.6 n/a 10.0 30.9
Growth −34.7% +407.1% −97.7% +26.4% +209.1%
n/a n/a 0.2 n/a n/a n/a n/a n/a n/a n/a
19.8 46.4 43.6 45.8 41.4 39.3 50.6 61.4 81.3 114.6
17.2 21.4 77.3 101.2 62.8 24.1 25.0 30.7 43.6 81.1
−37.0 −67.8 −94.8 −132.3 −49.4 −61.4 −72.9 −92.1 −115.0 −170.1
Growth
n/a n/a −72.4 −149.2 −67.5 −71.2 −73.8 −87.4 −130.5 −209.5
n/a n/a 0.0 0.0 0.2 0.0 0.0 n/a 0.2 n/a
−36.4 −67.8 −72.4 −149.2 −67.7 −71.2 −73.8 −87.4 −130.6 −209.5
Growth
Per share
−0.99 −1.76 −1.12 −2.00 −0.44 −4.90 −4.57 −3.96 −3.66 −3.02
−0.99 −1.76 −1.37 −2.00 −0.44 −4.90 −4.57 −3.96 −3.66 −3.02
Growth
37.0 38.4 65.0 74.6 153.3 14.5 16.1 22.1 35.7 69.3
37.0 38.4 69.3 74.6 0.2 14.5 16.1 22.1 35.7 69.3
Growth +3.9% +80.4% +7.6% −99.8% +9,379.6% +11.0% +36.7% +61.9% +94.1%

† The diluted share count jumps at 2018 and 2020 and 2021 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 12.1% a year over five years.
  • Operating margin is up 207.8 points on five years ago, at -550.3%.
  • A net loss in 10 of 10 years on file.